The online submission platform for ERDERA’s Joint Transnational Call 2025 is now live

We are pleased to announce that the platform for submitting project applications for the Joint Transnational Call for Proposals (JTC) 2025 is now officially live. This highly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.” 

How to Use the Platform 

The platform will allow you to: 

  • Register and provide all required personal data for project participants. 
  • Enter your finalised project description.

Access to the platform can be found here.

We strongly recommend registering early to familiarise yourself with the platform’s functionality. A template outlining the required data is available on the ERDERA Funding webpage to assist in your preparation. 

Application Timeline  

The JTC 2025 will follow a two-stage submission process:  

  • 13 February 2025: Pre-proposal submission deadline.  
  • 9 July 2025: Full proposals submission deadline.  

Funding decisions are expected by December 2025. 

For further details, access the updated call documents here. 

News & Updates

You might also be interested in

How careful symptom observation guides the diagnosis of rare diseases.
New international guidance supports decentralised clinical trials, pragmatic designs and the use of real-world data.
ERDERA will return to the World Orphan Drug Congress Europe with a booth and an interactive pre-conference workshop examining where artificial intelligence can support rare disease research and therapeutic development, and where human expertise remains essential.
Model award agreement document setting out the structure, articles and contractual provisions applicable to funded activities.